Related Experiment Videos

[The modern system for selection of cryptic plasmids based on replicon pMBI]

Voprosy Meditsinskoi Khimii
|May 1, 1983
PubMed

Insights

The hybrid plasmid pGalI

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • The hybrid plasmid pGalI exhibits cytotoxicity linked to its genome integration site.
  • This cytotoxic effect is influenced by flanking Eco RI recognition sites.

Purpose of the Study:

  • To investigate the factors limiting the cytotoxicity of the hybrid plasmid pGalI.
  • To explore the potential of other plasmids, such as pMB9 and those based on the pMBI replicon, in controlling pGalI cytotoxicity.
  • To establish a method for cloning plasmids as cryptic plasmids by limiting pGalI cytotoxicity.

Main Methods:

  • Analysis of the pGalI integration site and its association with cytotoxicity.
  • Co-transformation experiments with pGalI and other plasmids (pMB9, pMBI-based plasmids) in E. coli.
  • Selection of bacterial clones with a Gal+ phenotype to identify successful cryptic plasmid integration.

Main Results:

  • Plasmid pGalI's cytotoxicity is associated with a specific genome site (1.1 mD) and Eco RI restriction sites.
  • The cytotoxic effect of pGalI can be limited by co-transformation with plasmids like pMB9 or other pMBI-based plasmids.
  • A reduction in the copy number of pGalI correlates with limited cytotoxicity.
  • This limitation enabled the successful cloning of plasmids as cryptic plasmids in E. coli.

Conclusions:

  • The cytotoxicity of hybrid plasmid pGalI is site-specific and can be modulated by other plasmids.
  • Controlling pGalI copy number is key to mitigating its cytotoxic effects.
  • This study provides a method for generating cryptic plasmids by leveraging pGalI's controlled cytotoxicity.

Related Concept Videos